ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 19 filers reported holding ANI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $454,000 | +34.7% | 422,000 | +11.6% | 0.09% | +29.9% |
| Q1 2016 | $337,000 | -14.9% | 378,000 | -7.1% | 0.07% | -13.0% |
| Q4 2015 | $396,000 | +32.0% | 407,000 | +24.8% | 0.08% | +28.3% |
| Q3 2015 | $300,000 | -12.8% | 326,000 | +7.6% | 0.06% | -4.8% |
| Q2 2015 | $344,000 | – | 303,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 56,030 | $64,610,000 | 3.40% |
| MANGROVE PARTNERS IM, LLC | 18,779 | $21,537,000 | 2.90% |
| Worth Venture Partners, LLC | 1,102,000 | $1,275,000 | 1.41% |
| DLD Asset Management, LP | 10,250,000 | $11,896,000 | 0.86% |
| Perceptive Advisors | 7,500,000 | $8,642,000 | 0.29% |
| OAKTREE CAPITAL MANAGEMENT LP | 12,719,000 | $14,666,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 3,416,000 | $3,922,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,500,000 | $1,733,000 | 0.06% |
| Certified Advisory Corp | 42,000 | $48,000 | 0.03% |
| CSS LLC/IL | 500,000 | $577,000 | 0.03% |